Recording: What DIY investors need to know for 2023

Presented by
Tim Lincoln

Tim Lincoln

Co-Founder and
Managing Director

Matthew Swartz

Matthew Swartz

Senior Portfolio Manager

Kien Trinh

Kien Trinh

Head of Research

Dec 14th, 2022
1hr 12min

Many investors will be happy to say goodbye to 2022, but what should we expect to see in 2023?

Join us for our Stock Doctor 2023 Outlook Webinar featuring Co-Founder and Managing Director, Tim Lincoln, Senior Portfolio Manager, Matthew Swartz, and Head of Stock Doctor Research, Kien Trinh.

We are paying the price today for the sins of the past 15 years – cheap money, low-interest rates, and the central bank’s belief that the inflation dragon had been slayed. But how wrong they were.

With inflation hitting record highs and interest rates rising to match, investors were whacked with volatility and significant investment losses.

In this webinar, we share our combined 60+ years of investing experience to help you avoid the risks and identify the potential opportunities as you look ahead to 2023:

  • Avoid zombies – financially unhealthy companies at real and imminent risk of failure – that are likely already in your portfolio.
  • Should investors look to buy the next dip?
  • Derive sustainable income in a volatile and rising interest rate environment.
  • Take advantage of the key thematics that will play out in 2023.

Using Stock Doctor’s proprietary quantitative data-driven methodology, we are able to identify truly quality businesses and rule out the zombies. With more than two-thirds of the 2000 companies listed on the ASX showing signs of poor financial health, this can be harder than it looks without the right tools and methodology.

Join us as we help you cut through the noise, focus on the metrics that really matter, and most importantly, achieve long-term investment performance that meets your financial goals.

Presented by
Tim Lincoln

Tim Lincoln

Co-Founder and
Managing Director

Matthew Swartz

Matthew Swartz

Senior Portfolio Manager

Kien Trinh

Kien Trinh

Head of Research

Dec 14th, 2022
1hr 12min
Information in this communication is current as of publication unless otherwise stated. It is provided for educational purposes only and may not reflect current market data or opinion. It should not be relied upon in respect to any current investment decision. Investments can go up and down. Past performance is not a reliable indicator of future performance.

Important: This communication is provided by or on behalf of Lincoln Indicators Pty Limited ABN 23 006 715 573 (Lincoln), as Corporate Authorised Representative of Lincoln Financial Group Pty Ltd ABN 70 609 751 966, AFSL 483167 for information and educational purposes only. This content may contain general financial product advice. It has been prepared without taking account of your personal circumstances and you should therefore consider its appropriateness in light of your objectives, financial situation and needs, before acting on it. Investments can go up and down. Past performance is not a reliable indicator of future performance. Shares and other investments may go up and down in value, and their past performance may not be repeated and gives no guarantee of future performance. Information in this communication was current as at the date of its preparation, unless otherwise stated, and may be subject to change.

You should read and consider our Important Information and our Financial Services Guide (FSG) which sets out key information about the services we provide. Where our advice relates to the acquisition or possible acquisition of a particular financial product, you should obtain a copy of and consider the Lincoln Australian Income Fund Product Disclosure Statement (PDS), Lincoln Australian Growth Fund Product Disclosure Statement (PDS) and Lincoln U.S. Growth Fund Product Disclosure Statement (PDS) for the product at www.lincolnindicators.com.au before making any decision.

At the date of preparation of this communication, Lincoln, Lincoln Financial Group Pty Ltd or directors, employees and/or associates of these entities "may hold" interests in these ASX-listed companies. Further information about particular stocks held by these entities or persons from time to time is disclosed within the Stock Doctor program and may change at any time without notice.

Lincoln, Lincoln Financial Group Pty Ltd, any directors, employees and agents of these entities, make no representation and give no warranty as to the accuracy of this communication and do not accept any responsibility for any errors or inaccuracies in, or omissions from, this communication (whether negligent or otherwise) and are not liable for any loss or damage howsoever arising as a result of any person acting, or refraining from acting, in reliance on any information in this communication. No person should rely on this communication as it does not purport to be comprehensive. This disclaimer does not purport to exclude any rights under, or warranties implied by, law which may not be lawfully excluded.

Lincoln has taken precautions to minimise the risk of transmitting software viruses, but we advise you to carry out your own virus checks on any downloadable content. We do not accept liability for any loss or damage caused by software viruses.

Copyright © 2024 Lincoln Indicators Pty Ltd. All rights reserved.

All financial services are provided by Lincoln Indicators Pty Ltd ABN 23 006 715 573 (Lincoln) as the Corporate Authorised Representative of Lincoln Financial Group Pty Ltd ABN 70 609 751 966, AFSL 483167.

  • Show Popular Searches
  • Lincoln Indicators
  • Managed Funds
  • Investment Funds
  • Mutual Funds
  • Growth Funds
  • High Return Investments
  • Long Term Investments
  • Shares to Invest in Australia
  • Stock Portfolio Manager Software
  • Highest Dividend Stocks ASX
  • Highest Dividend Shares
  • Growth Stocks
  • ASX Stocks to Buy
  • Stock Research Reports
  • ASX Research Reports
  • Equity Funds
  • Hide Popular Searches